|
IQVIA™ Real-World Insights Bibliography
| COVID-19 patients analysis utilizing Japan and US claims databases |
| Author(s): Seok-Won Kim 1, T Ishii 2, Shujiro Takeno 2, Yuki Kado 2, Yuya Tamai 2, Takeshi Akiyama 2, Eric Yu 2, Sven Demiya 2 (rwesheorj 1) |
| Affiliations(s): 1) IQVIA Solutions Japan, Minato-ku, Tokyo, Japan |
Publication(s): ISPOR 2021 Conference
|
| Document Type(s): Poster, |
| Countries: Japan, |
| Click here for the abstract |
C:
Y: |
COVID-19,
2021 |
|
L:
A: |
English
Database Study, |
|
 |
| |
| |
| COVID-19 patient severities in Japanese EMR |
| Author(s): Masafumi Okada 1, Shingo Wada 1, Masaaki Isshiki 2, Sadako Utsunomiya 2, Takeshi Akiyama 1, Kenji Hamada 1, Sven Demiya 1 (rwesheorj 1) |
| Affiliations(s): 1,2) IQVIA Solutions Japan K.K., Minato-ku, Tokyo, Japan |
Publication(s): ISPOR 2021 Conference
|
| Document Type(s): Poster, |
| Countries: Japan, |
| Click here for the abstract |
C:
Y: |
COVID-19,
2021 |
|
L:
A: |
English
Database Study, |
|
|
| |
| |
| Understanding the COVID Impact on Healthcare System in Canada
|
| Author(s): Juejing Ling, Scott Shi, Marc Lapierre, HuijuanYang, Brad Millson
|
| Affiliations(s): Juejing Ling IQVIA, Scott Shi IQVIA, Marc Lapierre IQVIA, HuijuanYang IQVIA, Brad Millson IQVIA
|
Publication(s): 2021 CADTH Symposium Confrence, November 2, 3 and 4, 2021
|
| Document Type(s): Poster, |
| Countries: Canada, |
C:
Y: |
COVID-19,
2021 |
|
L:
A: |
English
Clinical setting: Primary care, Economic evaluation, |
|
|
| |
| |
| Prescribing patterns among in-person vs virtual primary care visits pre-and post-COVID-19 in Ontario, Canada
|
| Author(s): Muratov S, Neish D, Ellis K, Wang I, Yang H, Bhattacharjee P, Barot P, Kukaswadia A
|
| Affiliations(s): Muratov S, Neish D, Ellis K, Wang I, Yang H, Bhattacharjee P, Barot P, Kukaswadia A - all IQVIA authors
|
Publication(s): CAPT 2021 Confrence, October 25-27, 2021
|
| Document Type(s): Poster, |
| Countries: Canada, |
C:
Y: |
COVID-19,
2021 |
|
L:
A: |
English
Clinical setting: Primary care, Public Health, Survey research, |
|
|
| |
| |
| Who owns patient data? The answer is not that simple |
| Author(s): Alison Bourke, Georgina Bourke |
| Affiliations(s): Scientific Director, Centre of Advanced Evidence Generation, IQVIA, and Past President of the International Society for Pharmacoepidemiology.
Designer and Strategist at Projects by IF, a technology studio that focuses on the ethical and practical uses of data and AI. |
Publication(s): BJMOpinion
August 6, 2020
|
| Document Type(s): Article, |
| Countries: UK, USA, |
| Click here for the abstract |
C:
Y: |
COVID-19, Health policy,
2020 |
|
L:
A: |
English
Market impact, |
|
|
| |
| |
| Leveraging Real-World Data for COVID-19 Research: Challenges and Opportunities |
| Author(s): Matthew W. Reynolds, Jennifer B Christian, Christina D Mack, Marni Hall and Nancy A Dreyer |
| Affiliations(s): Matthew W. Reynolds, PhD, FISPE Vice President, Real World Evidence, IQVIA
Christina Mack, PhD, MSPH Vice President, Epidemiology and Clinical Evidence, IQVIA
Adjunct Faculty, UNC-Chapel Hill
Marni Hall, PhD, MPH
Vice President of Clinical Evidence, IQVIA
Nancy Dreyer, PhD, FISPE
Chief Scientific O?cer and Senior Vice President, IQVIA
Jennifer B. Christian, PharmD,
MPH, PhD, FISPE |
Publication(s): Precision Medicine 2020; 6 (2), June
|
| Document Type(s): Article, |
| Countries: USA, |
| Click here for the abstract |
C:
Y: |
COVID-19,
2020 |
|
L:
A: |
English
Data linkage, Observational study, Population Based Study, Real World Data, Real World Evidence, |
|
|
| |
| |
|
|
|
